Treatment of blood-related diseases, MOAB’s challenge


Blood-related diseases, goodbye to in vivo studies to evaluate the tumorigenicity of human hematopoietic stem cells modified by gene editing. They will soon be replaced by an in vitro model, a miniaturized bioreactor.


Startup Italia ‘s – Article link

Leave a Reply

Your email address will not be published. Required fields are marked *